Mark McDonough

Rob Dillard

DocwireNews

<a href="https://www.chromacode.com/" target="_blank" rel="noopener">ChromaCode</a> has developed an innovative high-definition PCR assay with cloud-based analysis for enhanced multiplexing and detection of biomarkers to guide targeted therapies in the most common cancer of the lung, non-small cell lung cancer (NSCLC), which currently has a 5-year survival rate of only 25.4%. Unfortunately, just 50% of patients undergo timely testing of driver mutations to facilitate targeted treatment. Cost, lack of local testing facilities, slow turnaround time, and insufficient or poor-quality tissue samples are the primary obstacles. The ChromaCode assay can help: turnaround time was a mere 3 hours, results were highly concordant with next-generation sequencing (NGS), and information was rescued from multiple samples that had input too low for NGS.Lung Cancers Today&nbsp;spoke with Mark McDonough, CEO of ChromaCode, to find out more about this innovative technology that may help patients with lung cancer.

Katie Kosko

Study Links Body Composition to Trastuzumab Deruxtecan Dosing, Toxicity

HER2 Breast Cancer

Pembrolizumab Plus Trastuzumab/Pertuzumab Shows Promise in HER2-Positive Breast Cancer

MarkAlain Déry, DO, MPH, FACOI

Autism Rates Reach New High in U.S. Children: Here’s What It Really Means

Neurodivergent

Latest News

A Rapid, Digital Test for Detecting Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Mark McDonough, CEO of ChromaCode, discusses an innovative, high-definition PCR assay for enhanced detection of NSCLC.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe